Mechanisms and Consequences of Cancer Genome Instability: Lessons from Genome Sequencing Studies

Annual Review of Pathology: Mechanisms of Disease

Volumn 11, Issue , 2016, Pages 283-312

  Lee, June Koo ^a   Choi, Yoon La ^b   Kwon, Mijung ^c,d   Park, Peter J ^c  

^a Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c HARVARD MEDICAL SCHOOL   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Aneuploidy; Cancer evolution; Chromosomal instability; Chromosomal rearrangement; Hypermutation; Microsatellite instability

Indexed keywords

CYTIDINE DEAMINASE;

ARTICLE; CANCER GENETICS; CANCER SURVIVAL; CARCINOGENESIS; CHROMOSOMAL INSTABILITY; COPY NUMBER VARIATION; EXCISION REPAIR; EXOME; GENE MUTATION; GENE SEQUENCE; GENOMIC INSTABILITY; GENOMICS; HUMAN; INDEL MUTATION; PRIORITY JOURNAL; TELOMERE; CELL TRANSFORMATION; GENETICS; NEOPLASM; PROCEDURES;

CELL TRANSFORMATION, NEOPLASTIC; GENOMIC INSTABILITY; GENOMICS; HUMANS; NEOPLASMS;

EID: 84971222718     PISSN: 15534006     EISSN: 15534014     Source Type: Book Series    
DOI: 10.1146/annurev-pathol-012615-044446     Document Type: Article

References (213)

1. Boveri T. 1914. Zur frage der entstehung maligner tumoren. Jena, Ger.: Gustav Fischer
2. Sieber OM, Heinimann K, Tomlinson IPM. 2003. Genomic instability-The engine of tumorigenesis? Nat. Rev. Cancer 3(9):701-8
3. Holland AJ, Cleveland DW. 2009. Boveri revisited: chromosomal instability, aneuploidy and tumorigenesis. Nat. Rev. Mol. Cell Biol. 10(7):478-87
4. Negrini S, Gorgoulis VG, Halazonetis TD. 2010. Genomic instability-an evolving hallmark of cancer. Nat. Rev. Mol. Cell Biol. 11(3):220-28
5. Hanahan D,Weinberg RA. 2011. Hallmarks of cancer: The next generation. Cell 144(5):646-74
6. Cooper GM. 1982. Cellular transforming genes. Science 217(4562):801-6
7. Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA, Kinzler KW. 2013. Cancer genome landscapes. Science 339(6127):1546-58
8. LawrenceMS, Stojanov P, MermelCH,Robinson JT,Garraway LA, et al. 2014. Discovery and saturation analysis of cancer genes across 21 tumour types. Nature 505(7484):495-501
9. Lengauer C, Kinzler KW, Vogelstein B. 1998. Genetic instabilities in human cancers. Nature 396(6712):643-49
10. GerlingerM, Rowan AJ, Horswell S, Larkin J, Endesfelder D, et al. 2012. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N. Engl. J. Med. 366(10):883-92
11. de Bruin EC, McGranahan N, Mitter R, Salm M, Wedge DC, et al. 2014. Spatial and temporal diversity in genomic instability processes defines lung cancer evolution. Science 346(6206):251-56
12. Zhang J, Fujimoto J, Zhang J, Zhang J, Wedge DC, et al. 2014. Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing. Science 346(6206):256-59
13. Sjöblom T, Jones S, Wood LD, Parsons DW, Lin J, et al. 2006. The consensus coding sequences of human breast and colorectal cancers. Science 314(5797):268-74
14. Wood LD, Parsons DW, Jones S, Lin J, Sjöblom T, et al. 2007. The genomic landscapes of human breast and colorectal cancers. Science 318(5853):1108-13
15. Lawrence MS, Stojanov P, Polak P, Kryukov GV, Cibulskis K, et al. 2013. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 499(7457):214-18
16. Alexandrov LB,Nik-Zainal S, WedgeDC, Aparicio SAJR, Behjati S, et al. 2013. Signatures of mutational processes in human cancer. Nature 500(7463):415-21
17. Mack S, Witt H, Piro R, Gu L, Zuyderduyn S, et al. 2014. Epigenomic alterations define lethal CIMPpositive ependymomas of infancy. Nature 506(7489):445-50
18. Cancer Genome Atlas Network. 2012. Comprehensive molecular characterization of human colon and rectal cancer. Nature 487(7407):330-37
19. Shaffer LG, McGowan-Jordan J, Schmid M. 2013. ISCN 2013: An International System for Human Cytogenetic Nomenclature (2013). Basel, Switz.: Karger
20. Kallioniemi A, Kallioniemi O-P, Sudar D, Rutovitz D, Gray JW, et al. 1992. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258(5083):818-21
21. Mei R, Galipeau PC, Prass C, Berno A, Ghandour G, et al. 2000. Genome-wide detection of allelic imbalance using human SNPs and high-density DNA arrays. Genome Res. 10(8):1126-37
22. Nowell PC, Hungerford DA. 1960. Chromosome studies on normal and leukemic human leukocytes. J. Natl. Cancer Inst. 25(1):85-109
23. Rowley JD. 2001. Chromosome translocations: dangerous liaisons revisited. Nat. Rev. Cancer 1(3):245-50
24. Yang L, Luquette LJ, Gehlenborg N, Xi R, Haseley PS, et al. 2013. Diverse mechanisms of somatic structural variations in human cancer genomes. Cell 153(4):919-29
25. Stephens PJ,McBride DJ, LinM-L, Varela I, Pleasance ED, et al. 2009. Complex landscapes of somatic rearrangement in human breast cancer genomes. Nature 462(7276):1005-10
26. Stephens PJ, Greenman CD, Fu B, Yang F, Bignell GR, et al. 2011. Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell 144(1):27-40
27. Gordon DJ, Resio B, Pellman D. 2012. Causes and consequences of aneuploidy in cancer. Nat. Rev. Genet. 13(3):189-203
28. Beroukhim R, Mermel CH, Porter D, Wei G, Raychaudhuri S, et al. 2010. The landscape of somatic copy-number alteration across human cancers. Nature 463(7283):899-905
29. Bignell GR, Greenman CD, Davies H, Butler AP, Edkins S, et al. 2010. Signatures of mutation and selection in the cancer genome. Nature 463(7283):893-98
30. Kim TM, Xi R, Luquette LJ, Park RW, Johnson MD, Park PJ. 2013. Functional genomic analysis of chromosomal aberrations in a compendium of 8000 cancer genomes. Genome Res. 23(2):217-27
31. Kops GJ, Weaver BA, Cleveland DW. 2005. On the road to cancer: aneuploidy and the mitotic checkpoint. Nat. Rev. Cancer 5(10):773-85
32. Michel LS, Liberal V, Chatterjee A, Kirchwegger R, Pasche B, et al. 2001. MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells. Nature 409(6818):355-59
33. Jeganathan K, Malureanu L, Baker DJ, Abraham SC, van Deursen JM. 2007. Bub1 mediates cell death in response to chromosome missegregation and acts to suppress spontaneous tumorigenesis. J. Cell Biol. 179(2):255-67
34. Rao CV, Yang YM, Swamy MV, Liu T, Fang Y, et al. 2005. Colonic tumorigenesis in BubR1+/-ApcMin/+ compound mutant mice is linked to premature separation of sister chromatids and enhanced genomic instability. PNAS 102(12):4365-70
35. Babu JR, Jeganathan KB, Baker DJ, Wu X, Kang-Decker N, van Deursen JM. 2003. Rae1 is an essential mitotic checkpoint regulator that cooperates with Bub3 to prevent chromosome missegregation. J. Cell Biol. 160(3):341-53
36. DaiW,Wang Q, Liu T, Swamy M, Fang Y, et al. 2004. Slippage of mitotic arrest and enhanced tumor development in mice with BUBR1 haploinsufficiency. Cancer Res. 64(2):440-45
37. Weaver BA, Silk AD, Montagna C, Verdier-Pinard P, Cleveland DW. 2007. Aneuploidy acts both oncogenically and as a tumor suppressor. Cancer Cell 11(1):25-36
38. Chesnokova V, Kovacs K, Castro AV, Zonis S, Melmed S. 2005. Pituitary hypoplasia in Pttg-/- mice is protective for Rb+/- pituitary tumorigenesis. Mol. Endocrinol. 19(9):2371-79
39. Torres EM, Sokolsky T, Tucker CM, Chan LY, Boselli M, et al. 2007. Effects of aneuploidy on cellular physiology and cell division in haploid yeast. Science 317(5840):916-24
40. Williams BR, Prabhu VR, Hunter KE, Glazier CM, Whittaker CA, et al. 2008. Aneuploidy affects proliferation and spontaneous immortalization in mammalian cells. Science 322(5902):703-9
41. Thompson SL,Compton DA. 2010. Proliferation of aneuploid human cells is limited by a p53-dependent mechanism. J. Cell Biol. 188(3):369-81
42. Torres EM, Dephoure N, Panneerselvam A, Tucker CM, Whittaker CA, et al. 2010. Identification of aneuploidy-tolerating mutations. Cell 143(1):71-83
43. SoliminiNL, Xu Q, Mermel CH, Liang AC, Schlabach MR, et al. 2012. Recurrent hemizygous deletions in cancers may optimize proliferative potential. Science 337(6090):104-9
44. Davoli T, Xu AW, Mengwasser KE, Sack LM, Yoon JC, et al. 2013. Cumulative haploinsufficiency and triplosensitivity drive aneuploidy patterns and shape the cancer genome. Cell 155(4):948-62
45. Macheret M, Halazonetis TD. 2015. DNA replication stress as a hallmark of cancer. Annu. Rev. Pathol. 10:425-48
46. ZemanMK, Cimprich KA. 2013. Causes and consequences of replication stress. Nat. Cell Biol. 16(1):2-9
47. Petermann E, OrtaML, Issaeva N, Schultz N, Helleday T. 2010. Hydroxyurea-stalled replication forks become progressively inactivated and require two different RAD51-mediated pathways for restart and repair. Mol. Cell 37(4):492-502
48. Bartkova J, Rezaei N, Liontos M, Karakaidos P, Kletsas D, et al. 2006. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 444(7119):633-37
49. Di Micco R, Fumagalli M, Cicalese A, Piccinin S, Gasparini P, et al. 2006. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 444(7119):638-42
50. Halazonetis TD, Gorgoulis VG, Bartek J. 2008. An oncogene-induced DNA damage model for cancer development. Science 319(5868):1352-55
51. Durkin SG, Glover TW. 2007. Chromosome fragile sites. Annu. Rev. Genet. 41:169-92
52. Gorgoulis VG, Vassiliou L-VF, Karakaidos P, Zacharatos P, Kotsinas A, et al. 2005. Activation of the DNAdamage checkpoint and genomic instability in human precancerous lesions. Nature 434(7035):907-13
53. Costantino L, Sotiriou SK, Rantala JK, Magin S, Mladenov E, et al. 2014. Break-induced replication repair of damaged forks induces genomic duplications in human cells. Science 343(6166):88-91
54. McBride DJ, Etemadmoghadam D, Cooke SL, Alsop K, George J, et al. 2012. Tandem duplication of chromosomal segments is common in ovarian and breast cancer genomes. J. Pathol. 227(4):446-55
55. Burrell RA, McClelland SE, Endesfelder D, Groth P, Weller M-C, et al. 2013. Replication stress links structural and numerical cancer chromosomal instability. Nature 494(7438):492-96
56. Coschi CH, Ishak CA, Gallo D, Marshall A, Talluri S, et al. 2014. Haploinsufficiency of an RB-E2F1-Condensin II complex leads to aberrant replication and aneuploidy. Cancer Discov. 4(7):840-53
57. Fearon ER, Vogelstein B. 1990. A genetic model for colorectal tumorigenesis. Cell 61(5):759-67
58. Weaver JMJ, Ross-Innes CS, Shannon N, Lynch AG, Forshew T, et al. 2014. Ordering of mutations in preinvasive disease stages of esophageal carcinogenesis. Nat. Genet. 46(8):837-43
59. Nordentoft I, Lamy P, Birkenkamp-DemtroderK, Shumansky K, Vang S, et al. 2014. Mutational context and diverse clonal development in early and late bladder cancer. Cell Rep. 7(5):1649-63
60. Tighe A, Johnson VL, Albertella M, Taylor SS. 2001. Aneuploid colon cancer cells have a robust spindle checkpoint. EMBO Rep. 2(7):609-14
61. Gascoigne KE, Taylor SS. 2008. Cancer cells display profound intra-and interline variation following prolonged exposure to antimitotic drugs. Cancer Cell 14(2):111-22
62. Cahill DP, Lengauer C, Yu J, Riggins GJ, Willson JKV, et al. 1998. Mutations of mitotic checkpoint genes in human cancers. Nature 392(6673):300-3
63. Barber TD, McManus K, Yuen KW, Reis M, Parmigiani G, et al. 2008. Chromatid cohesion defects may underlie chromosome instability in human colorectal cancers. PNAS 105(9):3443-48
64. Manning AL, Yazinski SA, Nicolay B, Bryll A, Zou L, DysonNJ. 2014. Suppression of genome instability in pRB-deficient cells by enhancement of chromosome cohesion. Mol. Cell 53(6):993-1004
65. Solomon DA, Kim T, Diaz-Martinez LA, Fair J, Elkahloun AG, et al. 2011. Mutational inactivation of STAG2 causes aneuploidy in human cancer. Science 333(6045):1039-43
66. Balbás-Martínez C, Sagrera A, Carrillo-de-Santa-Pau E, Earl J, Márquez M, et al. 2013. Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy. Nat. Genet. 45(12):1464-69
67. Thompson SL,Compton DA. 2008. Examining the link between chromosomal instability and aneuploidy in human cells. J. Cell Biol. 180(4):665-72
68. Holland AJ, ClevelandDW. 2012. Losing balance: The origin and impact of aneuploidy in cancer. EMBO Rep. 13(6):501-14
69. Bakhoum SF,Thompson SL, Manning AL, Compton DA. 2009. Genome stability is ensured by temporal control of kinetochore-microtubule dynamics. Nat. Cell Biol. 11(1):27-35
70. Bakhoum SF, Genovese G, Compton DA. 2009. Deviant kinetochore microtubule dynamics underlie chromosomal instability. Curr. Biol. 19(22):1937-42
71. Ganem NJ, Godinho SA, Pellman D. 2009. A mechanism linking extra centrosomes to chromosomal instability. Nature 460(7252):278-82
72. Quintyne NJ, Reing JE, Hoffelder DR, Gollin SM, Saunders WS. 2005. Spindle multipolarity is prevented by centrosomal clustering. Science 307(5706):127-29
73. Storchova Z, Kuffer C. 2008. The consequences of tetraploidy and aneuploidy. J. Cell Sci. 121(Pt. 23):3859-66
74. Levine DS, Rabinovitch PS, Haggitt RC, Blount PL, Dean PJ, et al. 1991. Distribution of aneuploid cell populations in ulcerative colitis with dysplasia or cancer. Gastroenterology 101(5):1198-210
75. Galipeau PC, Cowan DS, Sanchez CA, Barrett MT, Emond MJ, et al. 1996. 17p (p53) allelic losses, 4N (G2/tetraploid) populations, and progression to aneuploidy in Barrett's esophagus. PNAS 93(14):7081-84
76. Olaharski AJ, Sotelo R, Solorza-Luna G, Gonsebatt ME, Guzman P, et al. 2006. Tetraploidy and chromosomal instability are early events during cervical carcinogenesis. Carcinogenesis 27(2):337-43
77. Fodde R, Kuipers J, Rosenberg C, Smits R, Kielman M, et al. 2001. Mutations in the APC tumour suppressor gene cause chromosomal instability. Nat. Cell Biol. 3(4):433-38
78. Wang X, Zhou YX, Qiao W, Tominaga Y, Ouchi M, et al. 2006. Overexpression of aurora kinase A in mouse mammary epithelium induces genetic instability preceding mammary tumor formation. Oncogene 25(54):7148-58
79. Dewhurst SM, McGranahan N, Burrell RA, Rowan AJ, Gronroos E, et al. 2014. Tolerance of wholegenome doubling propagates chromosomal instability and accelerates cancer genome evolution. Cancer Discov. 4(2):175-85
80. Selmecki AM,Maruvka YE, Richmond PA,GuilletM, Shoresh N, et al. 2015. Polyploidy can drive rapid adaptation in yeast. Nature 519(7543):349-52
81. Fujiwara T, Bandi M, Nitta M, Ivanova EV, Bronson RT, Pellman D. 2005. Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells. Nature 437(7061):1043-47
82. Maser RS, DePinho RA. 2002. Connecting chromosomes, crisis, and cancer. Science 297(5581):565-69
83. Artandi SE, DePinho RA. 2010. Telomeres and telomerase in cancer. Carcinogenesis 31(1):9-18
84. Engelhardt M, Drullinsky P, Guillem J, Moore MA. 1997. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer. Clin. Cancer Res. 3(11):1931-41
85. Roger L, Jones RE, Heppel NH, Williams GT, Sampson JR, Baird DM. 2013. Extensive telomere erosion in the initiation of colorectal adenomas and its association with chromosomal instability. J. Natl. Cancer Inst. 105(16):1202-11
86. Chin K, de Solorzano CO, Knowles D, Jones A, Chou W, et al. 2004. In situ analyses of genome instability in breast cancer. Nat. Genet. 36(9):984-88
87. McClintock B. 1938. The production of homozygous deficient tissues with mutant characteristics by means of the aberrant mitotic behavior of ring-shaped chromosomes. Genetics 23(4):315-76
88. De Lange T. 2005. Telomere-related genome instability in cancer. Cold Spring Harb. Symp. Quant. Biol. 70:197-204
89. Artandi SE, Chang S, Lee SL, Alson S, Gottlieb GJ, et al. 2000. Telomere dysfunction promotes nonreciprocal translocations and epithelial cancers in mice. Nature 406(6796):641-45
90. O'Hagan RC, Chang S, Maser RS, Mohan R, Artandi SE, et al. 2002. Telomere dysfunction provokes regional amplification and deletion in cancer genomes. Cancer Cell 2(2):149-55
91. Else T, Trovato A, Kim AC,Wu Y, Ferguson DO, et al. 2009. Genetic p53 deficiency partially rescues the adrenocortical dysplasia phenotype at the expense of increased tumorigenesis. Cancer Cell 15(6):465-76
92. Davoli T, Denchi EL, de Lange T. 2010. Persistent telomere damage induces bypass of mitosis and tetraploidy. Cell 141(1):81-93
93. Carter SL, Cibulskis K, Helman E, McKenna A, Shen H, et al. 2012. Absolute quantification of somatic DNA alterations in human cancer. Nat. Biotechnol. 30(5):413-21
94. Lovejoy CA, LiW, Reisenweber S, Thongthip S, Bruno J, et al. 2012. Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathway. PLOS Genet. 8(7):e1002772
95. Zack TI, Schumacher SE, Carter SL, Cherniack AD, Saksena G, et al. 2013. Pan-cancer patterns of somatic copy number alteration. Nat. Genet. 45(10):1134-40
96. Xi R, Hadjipanayis AG, Luquette LJ, Kim TM, Lee E, et al. 2011. Copy number variation detection in whole-genome sequencing data using the Bayesian information criterion. PNAS 108(46):E1128-36
97. Gong Y, Zack TI,Morris LG, Lin K, Hukkelhoven E, et al. 2014. Pan-cancer genetic analysis identifies PARK2 as a master regulator of G1/S cyclins. Nat. Genet. 46(6):588-94
98. BrennanCW, Verhaak RGW, McKenna A, Campos B, NoushmehrH, et al. 2013. The somatic genomic landscape of glioblastoma. Cell 155(2):462-77
99. Myllykangas S, Himberg J, Bohling T, Nagy B, Hollmen J, Knuutila S. 2006. DNA copy number amplification profiling of human neoplasms. Oncogene 25(55):7324-32
100. Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, et al. 2005. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310(5748):644-48
101. Soda M, Choi YL, Enomoto M, Takada S, Yamashita Y, et al. 2007. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 448(7153):561-66
102. Takeuchi K, Soda M, Togashi Y, Suzuki R, Sakata S, et al. 2012. RET, ROS1 and ALK fusions in lung cancer. Nat. Med. 18(3):378-81
103. Druker BJ, Talpaz M, Resta DJ, Peng B, Buchdunger E, et al. 2001. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N. Engl. J.Med. 344(14):1031-37
104. Kwak EL, Bang YJ, Camidge DR, Shaw AT, Solomon B, et al. 2010. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. N. Engl. J. Med. 363(18):1693-703
105. MaherCA, Kumar-Sinha C, Cao X, Kalyana-Sundaram S, Han B, et al. 2009. Transcriptome sequencing to detect gene fusions in cancer. Nature 458(7234):97-101
106. Ju YS,LeeWC,Shin JY, Lee S,BleazardT, et al. 2012.Atransforming KIF5B andRETgene fusion in lung adenocarcinoma revealed from whole-genome and transcriptome sequencing. Genome Res. 22(3):436-45
107. Singh D, Chan JM, Zoppoli P, Niola F, Sullivan R, et al. 2012. Transforming fusions of FGFR and TACC genes in human glioblastoma. Science 337(6099):1231-35
108. Korbel JO, Urban AE, Affourtit JP, Godwin B, Grubert F, et al. 2007. Paired-end mapping reveals extensive structural variation in the human genome. Science 318(5849):420-26
109. Campbell PJ, Stephens PJ, Pleasance ED, O'Meara S, Li H, et al. 2008. Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing. Nat. Genet. 40(6):722-29
110. Drier Y, Lawrence MS, Carter SL, Stewart C, Gabriel SB, et al. 2013. Somatic rearrangements across cancer reveal classes of samples with distinct patterns of DNA breakage and rearrangement-induced hypermutability. Genome Res. 23(2):228-35
111. Hastings PJ, Lupski JR, Rosenberg SM, Ira G. 2009. Mechanisms of change in gene copy number. Nat. Rev. Genet. 10(8):551-64
112. Lee E, Iskow R, Yang L, Gokcumen O, Haseley P, et al. 2012. Landscape of somatic retrotransposition in human cancers. Science 337(6097):967-71
113. Solyom S, Ewing AD, Rahrmann EP, Doucet T, Nelson HH, et al. 2012. Extensive somatic L1 retrotransposition in colorectal tumors. Genome Res. 22(12):2328-38
114. Helman E, LawrenceMS, StewartC, SougnezC,GetzG,MeyersonM. 2014. Somatic retrotransposition in human cancer revealed by whole-genome and exome sequencing. Genome Res. 24(7):1053-63
115. Tubio JMC, Li Y, Ju YS, Martincorena I, Cooke SL, et al. 2014. Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes. Science 345(6196):1251343
116. Miki Y, Nishisho I, Horii A, Miyoshi Y, Utsunomiya J, et al. 1992. Disruption of the APC gene by a retrotransposal insertion of L1 sequence in a colon cancer. Cancer Res. 52(3):643-45
117. Iskow RC, McCabe MT, Mills RE, Torene S, Pittard WS, et al. 2010. Natural mutagenesis of human genomes by endogenous retrotransposons. Cell 141(7):1253-61
118. Korbel JO, Campbell PJ. 2013. Criteria for inference of chromothripsis in cancer genomes. Cell 152(6):1226-36
119. Forment JV, Kaidi A, Jackson SP. 2012. Chromothripsis and cancer: causes and consequences of chromosome shattering. Nat. Rev. Cancer 12(10):663-70
120. Holland AJ, Cleveland DW. 2012. Chromoanagenesis and cancer: mechanisms and consequences of localized, complex chromosomal rearrangements. Nat. Med. 18(11):1630-38
121. Crasta K, GanemNJ, Dagher R, Lantermann AB, Ivanova EV, et al. 2013.DNAbreaks and chromosome pulverization from errors in mitosis. Nature 482(7383):53-58
122. Hatch EM, Fischer AH, Deerinck TJ, Hetzer MW. 2013. Catastrophic nuclear envelope collapse in cancer cell micronuclei. Cell 154(1):47-60
123. Zhang CZ, Spektor A, Cornils H, Francis JM, Jackson EK, et al. 2015. Chromothripsis from DNA damage in micronuclei. Nature 522(7555):179-84
124. Liu P, Erez A, Nagamani SCS, Dhar SU, Kołodziejska KE, et al. 2011. Chromosome catastrophes involve replication mechanisms generating complex genomic rearrangements. Cell 146(6):889-903
125. Rausch T, Jones DTW, Zapatka M, Stütz AM, Zichner T, et al. 2012. Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations. Cell 148(1-2):59-71
126. Belton JM, McCord RP, Gibcus JH, Naumova N, Zhan Y, Dekker J. 2012. Hi-C: A comprehensive technique to capture the conformation of genomes. Methods 58(3):268-76
127. Zhang J, Poh HM, Peh SQ, Sia YY, Li G, et al. 2012. ChIA-PET analysis of transcriptional chromatin interactions. Methods 58(3):289-99
128. Fudenberg G, Getz G, Meyerson M, Mirny LA. 2011. High order chromatin architecture shapes the landscape of chromosomal alterations in cancer. Nat. Biotechnol. 29(12):1109-13
129. Wijchers PJ, de Laat W. 2011. Genome organization influences partner selection for chromosomal rearrangements. Trends Genet. 27(2):63-71
130. Zhang Y,McCord RP,Ho YJ, Lajoie BR,Hildebrand DG, et al. 2012. Spatial organization of the mouse genome and its role in recurrent chromosomal translocations. Cell 148(5):908-21
131. Lieberman-Aiden E, van Berkum NL, Williams L, Imakaev M, Ragoczy T, et al. 2009. Comprehensive mapping of long-range interactions reveals folding principles of the human genome. Science 326(5950):289-93
132. Schleiermacher G, Janoueix-Lerosey I,CombaretV,Derre J, Couturier J, et al. 2003. Combined 24-color karyotyping and comparative genomic hybridization analysis indicates predominant rearrangements of early replicating chromosome regions in neuroblastoma. Cancer Genet. Cytogenet. 141(1):32-42
133. Barlow JH, Faryabi RB, Callen E,Wong N,Malhowski A, et al. 2013. Identification of early replicating fragile sites that contribute to genome instability. Cell 152(3):620-32
134. Pedersen BS, De S. 2013. Loss of heterozygosity preferentially occurs in early replicating regions in cancer genomes. Nucleic Acids Res. 41(16):7615-24
135. Kitamura E, Blow JJ, Tanaka TU. 2006. Live-cell imaging reveals replication of individual replicons in eukaryotic replication factories. Cell 125(7):1297-308
136. Preston BD, Albertson TM, Herr AJ. 2010. DNA replication fidelity and cancer. Semin. Cancer Biol. 20(5):281-93
137. Kim T-M, Laird PW, Park PJ. 2013. The landscape of microsatellite instability in colorectal and endometrial cancer genomes. Cell 155(4):858-68
138. Tomlinson IPM,Novelli MR, Bodmer WF. 1996. Themutation rate and cancer. PNAS 93(25):14800-3
139. Fox EJ, Prindle MJ, Loeb LA. 2013. Do mutator mutations fuel tumorigenesis? Cancer Metastasis Rev. 32(3-4):353-61
140. Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. 2013. Emerging landscape of oncogenic signatures across human cancers. Nat. Genet. 45(10):1127-33
141. Westcott PMK, Halliwill KD, To MD, Rashid M, Rust AG, et al. 2014. The mutational landscapes of genetic and chemical models of Kras-driven lung cancer. Nature 517(7535):489-92
142. Shinbrot E, Henninger EE, Weinhold N, Covington KR, Goksenin AY, et al. 2014. Exonuclease mutations in DNA polymerase epsilon reveal replication strand specific mutation patterns and human origins of replication. Genome Res. 24(11):1740-50
143. Henderson S, Chakravarthy A, Su X, Boshoff C, Fenton TR. 2014. APOBEC-mediated cytosine deamination links PIK3CA helical domain mutations to human papillomavirus-driven tumor development. Cell Rep. 7(6):1833-41
144. Shlien A, Campbell BB, de Borja R, Alexandrov LB, Merico D, et al. 2015. Combined hereditary and somatic mutations of replication error repair genes result in rapid onset of ultra-hypermutated cancers. Nat. Genet. 47(3):257-62
145. LlosaNJ, Cruise M,TamA,WicksEC, Hechenbleikner EM, et al. 2015. The vigorous immune microenvironment ofmicrosatellite instable colon cancer is balanced bymultiple counter-inhibitory checkpoints. Cancer Discov. 5(1):43-51
146. Le DT, Uram JN, Wang H, Bartlett BR, Kemberling H, et al. 2015. PD-1 blockade in tumors with mismatch-repair deficiency. N. Engl. J. Med. 372(26):2509-20
147. Peltomaki P. 2003. Role of DNA mismatch repair defects in the pathogenesis of human cancer. J. Clin. Oncol. 21(6):1174-79
148. Aaltonen LA, Peltomaki P, Leach FS, Sistonen P, Pylkkanen L, et al. 1993. Clues to the pathogenesis of familial colorectal cancer. Science 260(5109):812-16
149. Thibodeau SN, BrenG, Schaid D. 1993. Microsatellite instability in cancer of the proximal colon. Science 260(5109):816-19
150. Ionov Y, Peinado MA, Malkhosyan S, Shibata D, Perucho M. 1993. Ubiquitous somatic mutations in simple repeated sequences reveal a newmechanism for colonic carcinogenesis. Nature 363(6429):558-61
151. de la Chapelle A, Hampel H. 2010. Clinical relevance of microsatellite instability in colorectal cancer. J. Clin. Oncol. 28(20):3380-87
152. Lynch HT, de la Chapelle A. 2003. Hereditary colorectal cancer. N. Engl. J. Med. 348(10):919-32
153. Cancer Genome Atlas Research Network. 2013. Integrated genomic characterization of endometrial carcinoma. Nature 497(7447):67-73
154. Cancer Genome Atlas Research Network. 2014. Comprehensive molecular characterization of gastric adenocarcinoma. Nature 513(7517):202-9
155. Popat S, Hubner R, Houlston R. 2005. Systematic review of microsatellite instability and colorectal cancer prognosis. J. Clin. Oncol. 23(3):609-18
156. Ribic CM, Sargent DJ, Moore MJ, Thibodeau SN, French AJ, et al. 2003. Tumor microsatelliteinstability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N. Engl. J. Med. 349(3):247-57
157. Tajima A, Hess MT, Cabrera BL, Kolodner RD, Carethers JM. 2004. The mismatch repair complex hMutSα recognizes 5-fluorouracil-modified DNA: implications for chemosensitivity and resistance. Gastroenterology 127(6):1678-84
158. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, et al. 1998. A national cancer institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 58(22):5248-57
159. Kim TM, Park PJ. 2014. A genome-wide view of microsatellite instability: old stories of cancermutations revisited with new sequencing technologies. Cancer Res. 74(22):6377-82
160. Herman JG, Umar A, Polyak K, Graff JR, Ahuja N, et al. 1998. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. PNAS 95(12):6870-75
161. Laiho P, Launonen V, Lahermo P, Esteller M, Guo M, et al. 2002. Low-level microsatellite instability in most colorectal carcinomas. Cancer Res. 62(4):1166-70
162. Kuismanen SA, Moisio AL, Schweizer P, Truninger K, Salovaara R, et al. 2002. Endometrial and colorectal tumors from patients with hereditary nonpolyposis colon cancer display different patterns of microsatellite instability. Am. J. Pathol. 160(6):1953-58
163. Umar A, Boland CR, Terdiman JP, Syngal S, de la Chapelle A, et al. 2004. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J. Natl. Cancer Inst. 96(4):261-68
164. Schuster-Bockler B, Lehner B. 2012. Chromatin organization is a major influence on regional mutation rates in human cancer cells. Nature 488(7412):504-7
165. Supek F, Lehner B. 2015. Differential DNA mismatch repair underlies mutation rate variation across the human genome. Nature 521:81-84
166. Heitzer E, Tomlinson I. 2014. Replicative DNA polymerase mutations in cancer. Curr. Opin. Genet. Dev. 24:107-13
167. da Costa LT, Liu B, el-Deiry W, Hamilton SR, Kinzler KW, et al. 1995. Polymerase delta variants in RER colorectal tumours. Nat. Genet. 9(1):10-11
168. Flohr T, Dai JC, Buttner J, Popanda O, Hagmuller E, Thielmann HW. 1999. Detection of mutations in the DNA polymerase δ gene of human sporadic colorectal cancers and colon cancer cell lines. Int. J. Cancer 80(6):919-29
169. Palles C, Cazier J-B, Howarth KM, Domingo E, Jones AM, et al. 2013. Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas. Nat. Genet. 45(2):136-44
170. Church DN, Stelloo E,Nout RA, Valtcheva N, Depreeuw J, et al. 2015. Prognostic significance of POLE proofreading mutations in endometrial cancer. J. Natl. Cancer Inst. 107(1):402
171. Pursell ZF, Isoz I, Lundström E-B, Johansson E,KunkelTA. 2007. YeastDNApolymerase ϵparticipates in leading-strand DNA replication. Science 317(5834):127-30
172. McElhinny SAN, Gordenin DA, Stith CM, Burgers PM, Kunkel TA. 2008. Division of labor at the eukaryotic replication fork. Mol. Cell 30(2):137-44
173. Krokan HE, Bjoras M. 2013. Base excision repair. Cold Spring Harb. Perspect. Biol. 5(4):a012583
174. Hecht SS. 1999. Tobacco smoke carcinogens and lung cancer. J. Natl. Cancer Inst. 91(14):1194-210
175. David SS, O'Shea VL, Kundu S. 2007. Base-excision repair of oxidative DNA damage. Nature 447(7147):941-50
176. Topal MD, Baker MS. 1982. DNA precursor pool: A significant target for N-methyl-N-nitrosourea in C3H/10T1/2 clone 8 cells. PNAS 79(7):2211-15
177. Huycke MM, Gaskins HR. 2004. Commensal bacteria, redox stress, and colorectal cancer: mechanisms and models. Exp. Biol. Med. 229(7):586-97
178. Al-Tassan N, Chmiel NH, Maynard J, Fleming N, Livingston AL, et al. 2002. Inherited variants of MYH associated with somatic G:C→T:A mutations in colorectal tumors. Nat. Genet. 30(2):227-32
179. Lipton L, Halford SE, Johnson V, Novelli MR, Jones A, et al. 2003. Carcinogenesis in MYH-associated polyposis follows a distinct genetic pathway. Cancer Res. 63(22):7595-99
180. Smith CG, West H, Harris R, Idziaszczyk S, Maughan TS, et al. 2013. Role of the oxidative DNA damage repair gene OGG1 in colorectal tumorigenesis. J. Natl. Cancer Inst. 105(16):1249-53
181. Kinnersley B, Buch S, Castellvi-Bel S, Farrington SM, Forsti A, et al. 2014. Re: Role of the oxidative DNA damage repair gene OGG1 in colorectal tumorigenesis. J. Natl. Cancer Inst. 106(5):dju086
182. Speina E, Arczewska KD, Gackowski D, Zielinska M, Siomek A, et al. 2005. Contribution of hMTH1 to the maintenance of 8-oxoguanine levels in lung DNA of non-small-cell lung cancer patients. J. Natl. Cancer Inst. 97(5):384-95
183. GadH, KoolmeisterT, Jemth A-S, Eshtad S, Jacques SA, et al. 2014.MTH1inhibition eradicates cancer by preventing sanitation of the dNTP pool. Nature 508(7495):215-21
184. Huber KVM, Salah E, Radic B, Gridling M, Elkins JM, et al. 2014. Stereospecific targeting of MTH1 by (S)-crizotinib as an anticancer strategy. Nature 508(7495):222-27
185. Helleday T. 2014. Cancer phenotypic lethality, exemplified by the non-essential MTH1 enzyme being required for cancer survival. Ann. Oncol. 25(7):1253-55
186. de Laat WL, Jaspers NG, Hoeijmakers JH. 1999. Molecular mechanism of nucleotide excision repair. Genes Dev. 13(7):768-85
187. DiGiovanna JJ, Kraemer KH. 2012. Shining a light on xeroderma pigmentosum. J. Investig. Dermatol. 132(3 Pt. 2):785-96
188. Cleaver JE. 1968. Defective repair replication of DNA in xeroderma pigmentosum. Nature 218(5142):652-56
189. Dumaz N, Drougard C, Sarasin A, Daya-Grosjean L. 1993. Specific UV-induced mutation spectrum in the p53 gene of skin tumors from DNA-repair-deficient xeroderma pigmentosum patients. PNAS 90(22):10529-33
190. BodakN,Queille S, AvrilMF, Bouadjar B, DrougardC, et al. 1999. High levels of patched gene mutations in basal-cell carcinomas from patients with xeroderma pigmentosum. PNAS 96(9):5117-22
191. Lee W, Jiang Z, Liu J, Haverty PM, Guan Y, et al. 2010. The mutation spectrum revealed by paired genome sequences from a lung cancer patient. Nature 465(7297):473-77
192. Pleasance ED, Stephens PJ, O'Meara S, McBride DJ, Meynert A, et al. 2010. A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature 463(7278):184-90
193. Polak P, LawrenceMS, Haugen E, Stoletzki N, Stojanov P, et al. 2014. Reduced local mutation density in regulatory DNA of cancer genomes is linked to DNA repair. Nat. Biotechnol. 32(1):71-75
194. Yasuda T, Sugasawa K, Shimizu Y, Iwai S, Shiomi T, Hanaoka F. 2005. Nucleosomal structure of undamaged DNA regions suppresses the non-specific DNA binding of the XPC complex. DNA Repair 4(3):389-95
195. Nik-Zainal S, Alexandrov LB,Wedge DC, Van Loo P,Greenman CD, et al. 2012. Mutational processes molding the genomes of 21 breast cancers. Cell 149(5):979-93
196. Roberts SA, Sterling J, Thompson C, Harris S, Mav D, et al. 2012. Clustered mutations in yeast and in human cancers can arise from damaged long single-strand DNA regions. Mol. Cell 46(4):424-35
197. Sakofsky CJ, Roberts SA, Malc E, Mieczkowski PA, Resnick MA, et al. 2014. Break-induced replication is a source of mutation clusters underlying kataegis. Cell Rep. 7(5):1640-48
198. Conticello SG. 2008. The AID/APOBEC family of nucleic acid mutators. Genome Biol. 9(6):229
199. Harris RS, Petersen-Mahrt SK, Neuberger MS. 2002. RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators. Mol. Cell 10(5):1247-53
200. Roberts SA, Lawrence MS, Klimczak LJ, Grimm SA, Fargo D, et al. 2013. An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers. Nat. Genet. 45(9):970-76
201. Burns MB, Temiz NA, Harris RS. 2013. Evidence for APOBEC3B mutagenesis in multiple human cancers. Nat. Genet. 45(9):977-83
202. Burns MB, Lackey L, Carpenter MA, Rathore A, Land AM, et al. 2013. APOBEC3B is an enzymatic source of mutation in breast cancer. Nature 494(7437):366-70
203. Taylor BJ, Nik-Zainal S, Wu YL, Stebbings LA, Raine K, et al. 2013. DNA deaminases induce breakassociated mutation showers with implication of APOBEC3B and 3A in breast cancer kataegis. eLife 2:e00534
204. Nik-Zainal S, Wedge DC, Petljak M, Butler AP, Bolli N, et al. 2014. Association of a germline copy number polymorphism of APOBEC3A and APOBEC3B with burden of putative APOBEC-dependent mutations in breast cancer. Nat. Genet. 46(5):487-91
205. Long J, Delahanty RJ, Li G, Gao Y-T, Lu W, et al. 2013. A common deletion in the APOBEC3 genes and breast cancer risk. J. Natl. Cancer Inst. 105(8):573-79
206. Qian J, Wang Q, Dose M, Pruett N, Kieffer-KwonKR, et al. 2014. B cell super-enhancers and regulatory clusters recruit AID tumorigenic activity. Cell 159(7):1524-37
207. Bolli N, Avet-Loiseau H, WedgeDC, Van Loo P, Alexandrov LB, et al. 2014. Heterogeneity of genomic evolution and mutational profiles in multiple myeloma. Nat. Commun. 5:2997
208. Meng FL, Du Z, Federation A, Hu J, Wang Q, et al. 2014. Convergent transcription at intragenic super-enhancers targets AID-initiated genomic instability. Cell 159(7):1538-48
209. Patel AP, Tirosh I, Trombetta JJ, Shalek AK, Gillespie SM, et al. 2014. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science 344(6190):1396-401
210. Bedard PL, Hansen AR, Ratain MJ, Siu LL. 2013. Tumour heterogeneity in the clinic. Nature 501(7467):355-64
211. Campbell PJ, Yachida S, Mudie LJ, Stephens PJ, Pleasance ED, et al. 2010. The patterns and dynamics of genomic instability in metastatic pancreatic cancer. Nature 467(7319):1109-13
212. Johnson BE, Mazor T, Hong C, Barnes M, Aihara K, et al. 2013. Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma. Science 343(6167):189-93
213. Hunter C, Smith R, Cahill DP, Stephens P, Stevens C, et al. 2006. A hypermutation phenotype and somatic MSH6 mutations in recurrent human malignant gliomas after alkylator chemotherapy. Cancer Res. 66(8):3987-91